These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 2433838

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Non-A, non-B hepatitis-related antigens and antibodies and experimental infection].
    Yoshizawa H.
    Rinsho Byori; 1984 Nov; 32(11):1202-12. PubMed ID: 6084080
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical aspects and risk factors in posttransfusion hepatitis].
    Realdi G, Tremolada F, Chiappetta F, Antona C, Noventa F, Loreggian M, Chemello L, Alberti A.
    Ric Clin Lab; 1984 Nov; 14 Suppl 1():17-35. PubMed ID: 6330858
    [No Abstract] [Full Text] [Related]

  • 4. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
    Bedarida G, Cambiè G, D'Agostino F, Sterza G.
    Ric Clin Lab; 1984 Nov; 14 Suppl 1():37-60. PubMed ID: 6429830
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Non-A, non-B posttransfusion hepatitis: comparing C and non-C hepatitis.
    Koretz RL, Brezina M, Polito AJ, Quan S, Wilber J, Dinello R, Gitnick G.
    Hepatology; 1993 Mar; 17(3):361-5. PubMed ID: 8383087
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Based on your analysis of the benefits and costs of routine donor screening for ALT-GPT to reduce the incidence of post-transfusion non-A, non-B hepatitis in your blood services region, what action would you recommend on this matter?
    Vox Sang; 1983 Mar; 44(1):48-64. PubMed ID: 6402857
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Posttransfusion hepatitis.
    Straughn J.
    Del Med J; 1988 Oct; 60(10):585-6. PubMed ID: 3143608
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The clinical behaviour of by immunology unique courses of NANB hepatitis (author's transl)].
    Liehr H, Seelig R, Seelig HP.
    Z Gastroenterol; 1982 May; 20(5):278-85. PubMed ID: 6125065
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis.
    Kiyosawa K, Akahane Y, Nagata A, Furuta S.
    Am J Gastroenterol; 1984 Oct; 79(10):777-81. PubMed ID: 6091443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.